Renal dopamine, via activation of D1 receptors, plays a role in maintaining sodium homeostasis and BP. There exists a defect in renal D1 receptor function in hypertension, diabetes, and aging, conditions that are associated with oxidative stress. However, the exact underlying mechanism of the oxidative stress-mediated impaired D1 receptor signaling and hypertension is not known. The effect of oxidative stress on renal D1 receptor function was investigated in healthy animals. Male Sprague-Dawley rats received tap water (vehicle) and 30 mM L-buthionine sulfoximine (BSO), an oxidant, with and without 1 mM tempol for 2 wk. Compared with vehicle, BSO treatment caused oxidative stress and increase in BP, which was accompanied by defective D1 receptor G-protein coupling and loss of natriuretic response to SKF38393. BSO treatment also increased NF-B nuclear translocation, protein kinase C (PKC) activity and expression, G-protein-coupled receptor kinase-2 (GRK-2) membranous translocation, and D1 receptor serine phosphorylation. In BSO-treated rats' supplementation of tempol decreased oxidative stress, normalized BP, and restored D1 receptor G-protein coupling and natriuretic response to SKF38393. Tempol also normalized NF-B translocation, PKC activity and expression, GRK-2 sequestration, and D1 receptor serine phosphorylation. In conclusion, these results show that oxidative stress activates NF-B, causing an increase in PKC activity, which leads to GRK-2 translocation and subsequent D1 receptor hyper-serine phosphorylation and uncoupling. The functional consequence of this phenomenon was the inability of SKF38393 to inhibit Na/K-ATPase activity and promote sodium excretion, which may have contributed to increase in BP. Tempol reduced oxidative stress and thereby restored D1 receptor function and normalized BP.
D
opamine is recognized as an important regulator of sodium homeostasis and BP (1) . The effects of dopamine are exerted by cell surface receptors that belong to the rhodopsin-like family and are classified as D1-and D2-like receptors (2) . Dopamine, via D1 receptor activation, can inhibit Na/K-ATPase and Na/H-exchanger 3 (NHE3) on the basolateral and apical side of the renal proximal tubule, respectively, and increase sodium excretion (3) . Abnormalities in renal dopamine D1 receptor function have been described in both human and animal models of hypertension (4 -6) . In genetic hypertension, there is a failure of inhibition by D 1 -like receptor agonists of Na/K ATPase and NHE3 activities in the renal proximal tubule (4 -6) . In spontaneously hypertensive rats, Dahl salt-sensitive rats, obese Zucker rats, and young patients with essential hypertension, the defect is due to an abnormal regulation of D l -like receptor signal transduction (6 -10) . The failure of dopamine to inhibit sodium transporters is not caused by abnormalities in D1 receptor protein abundance, G proteins, or effector proteins. Rather, the D1 receptor is uncoupled from its G protein/effector complex, resulting in a decreased production of cytoplasmic second messengers that normally inhibit sodium transporters (6 -10) .
There is emerging evidence that in hypertensive conditions, the impaired renal D1 receptor signaling coexists with oxidative stress (7, (11) (12) (13) (14) . In our studies, we found that conditions such as aging, diabetes, and hypertension are associated with increased oxidative stress (7, 15, 16) . For example, we found increased oxidative stress in mildly hypertensive obese Zucker rats compare with lean rats (7) . Also, the ability of dopamine to inhibit sodium transporters and promote sodium excretion was markedly diminished in obese compared with lean rats (7) .
The most rapid means by which G-protein-coupled receptor (GPCR) are uncoupled from G-proteins and desensitized is via phosphorylation by intracellular kinases (17) . It is reported that both second messenger-dependent protein kinases such as protein kinase C (PKC) and GPCR kinases (GRK) phosphorylate intracellular serine and threonine residues of GPCR (17) (18) (19) . Previously, we showed that in obese Zucker rats, increased oxidative stress caused increased PKC activity and GRK-2 translocation, leading to D1 receptor desensitization (7) . Recently, in a more direct study, we showed that exposure of primary cultures to H 2 O 2 led to D1 receptor phosphorylation, which was caused by PKC activation and GRK-2 translocation (20) . Also, overwhelming evidence suggests that the dimeric NF-B transcription factors are key regulators in response to oxidative stress or inflammation (21, 22) . Upon stimulation, including oxidative stress, NF-B translocates into nucleus, where it further stimulates expression of target genes that are involved in important cellular events, including PKC (23, 24) .
Although there is evidence to suggest that reactive oxygen species (ROS) contribute to decreased D1 receptor function (7, 13, 20) , it is not known whether oxidative stress by itself causes defective renal D1 receptor function and hypertension, or the onset of hypertension leads to oxidative stress and subsequent D1 receptor dysfunction. To ascertain the role of oxidative stress in D1 receptor defect and hypertension, we treated normotensive Sprague-Dawley rats with l-buthionine sulfoximine (BSO), an oxidant, with and without the antioxidant tempol. At the end of the 2-wk treatment regimen, the rats were studied for oxidative stress; intracellular signaling molecules such as NF-B, PKC, and GRK-2; and D1 receptor signaling and function and BP.
Materials and Methods

Animals
Male Sprague-Dawley rats (Harlan, Indianapolis, IN) were fed a normal rat diet and divided into following groups: Vehicle, animals that were maintained on tap water; BSO, animals that were provided with 30 mM BSO (Sigma, St. Louis, MO); tempol, animals that were provided with 1 mM tempol (Sigma); and BSO ϩ tempol, animals that were provided with BSO supplemented with tempol. BSO, a ␥-glutamylcysteine synthetase inhibitor, and tempol, a superoxide dismutase (SOD) mimetic compound, were provided in drinking water for 2 wk. All experiments were performed according to University of Houston guidelines and protocols for care and use of laboratory animals.
Surgical Procedures for Renal Function Studies
Rats were anesthetized with Inactin (100 mg/kg intraperitoneally; Sigma), and a tracheotomy was performed to facilitate breathing (16) . For measurement of BP and heart rate, the left carotid artery was catheterized with PE-50 tubing and connected to a pressure transducer. Heart rate was monitored from a cardiotachograph, and both BP and heart rate were recorded on Grass polygraph (Grass Instrument, Quincy, MA).
Experimental Protocol for Renal Function Studies
For determination of the effect of SKF38393 (Sigma) on sodium and water excretion, rats were stabilized for 45 min after surgery and followed by five consecutive 30-min collection periods: C1, C2, D, R1, and R2. During C1 and C2, saline alone was infused; during D, SKF38393 (1 g/kg body wt per min in saline) was infused; and during R1 and R2 (recovery), only saline was infused (16) . Urine samples were collected throughout the 30-min periods. Sodium was measured by flame photometer (Cole-Parmer, Vernon Hills, IL), plasma and urine creatinine levels were measured with a creatinine analyzer (Beckman, Fullerton, CA), and fractional excretion of sodium was determined as described previously (16) . Blood glucose was measured by glucose analyzer (Roche, Indianapolis, IN), and urinary dopamine was measured by HPLC (Waters, Milford, MA).
Preparation of Renal Proximal Tubular Suspension
Renal proximal tubules were isolated as described by us previously (16) . Cell membranes were isolated by differential centrifugation (16), whereas nuclear and cytosolic fractions were isolated by a commercially available Kit (78833; Pierce, Rockford, IL). Protein was determined by bicinchoninic acid method (Pierce) using BSA as a standard.
Indices of Oxidative Stress
Renal glutathione levels were assayed by colorimetric assay kit (21023; OXIS, Foster City, CA), 8-isoprostane was measured by RIA kit (516351; Cayman, Ann Arbor, MI), and nitrotyrosine was determined by immunoblotting kit (Upstate, Charlottesville, VA). Malondialdehyde was determined by the method of Mihara and Uchiyama (25) . 
[ 3 H]SCH23390 Binding
Na/K-ATPase and NHE3 Assay
Na/K-ATPase activity was determined as reported previously (26) . Briefly, SKF38393-induced Na/K-ATPase inhibition was determined in renal proximal tubular suspensions (1 mg protein/ml) incubated with or without 1 mmol/L ouabain at 37°C for 15 min. NHE3 activity was determined by measurement of 5-(N-methyl-N-isobutyl)-amiloridesensitive 22 Na ϩ uptake (29) .
Immunoblotting
Proteins were solubilized in Laemmli buffer, separated by SDS-PAGE, and transferred to nitrocellulose membrane (16) . The membranes were blocked; incubated with antisera directed against GRK-2, PKC-␣/␤/␦, NF-B (SC-208/209/213; Santa Cruz Biotechnology, Santa Cruz, CA), D1A, G␣s/G␣i (371770; Calbiochem, San Diego, CA) in 0.1% TBS; and incubated with horseradish peroxidase-conjugated secondary antibodies (30) . For serine phosphorylation, D1A receptor was immunoprecipitated as described previously (31) .
Adenylyl Cyclase Assay
The adenylyl cyclase assay was performed as described previously (32 
Electrophoretic Mobility Shift Assay
The LightShift Chemiluminescent EMSA Kit (20148; Pierce) was used to detect biotinylated DNA-NF-B interactions. Electrophoretic mobility shift assay (EMSA) was performed with nuclear extracts using GAGAGGCAAGGGGATTCCCTTAGTTAGGA as sense sequence for NF-B. Nuclear extracts were incubated with NF-B-specific, biotinylated, double-stranded oligonucleotides in the presence or absence of 100-to 200-fold excess NF-B-specific, unlabeled, double-stranded oligonucleotides. Samples were separated on 6% DNA retardation gels (Invitrogen, Carlsbad, CA) and transferred to nylon membrane, and DNA was cross-linked to membrane at 254 nm of ultraviolet (UV) light. The bands were analyzed by chemiluminescence followed by densitometry with Kodak imaging station (Kodak, Rochester, NY) (24) .
Statistical Analyses
Differences between means were evaluated using the unpaired t test or ANOVA with Newman-Keuls multiple test, as appropriate. P Ͻ 0.05 was considered statistically significant.
Results
Animals that were supplemented with BSO, tempol, or both in drinking water had similar body weight and dietary consumption as rats that were drinking tap water (vehicle) alone (Table 1 ). There were no significant differences in blood glucose, urinary dopamine excretion, and GFR among the four experimental groups. Compared with vehicle-treated rats, rats that were treated with BSO exhibited an increase in BP (Table  1) . Tempol supplementation normalized the BP in BSO-treated rats, whereas rats that were provided with tempol alone had no effect on BP (Table 1) . Table 1 depicts the oxidative stress in various experimental groups. Treatment with BSO caused significant decrease in renal glutathione, a pivotal antioxidant. In addition, BSOtreated rats showed renal lipid peroxidation and protein oxidation as evidenced by significant increase in tissue malondialdehyde and nitrotyrosine (Table 1) . Also, a significant increase in plasma and urinary 8-isoprostane was observed in BSO-treated rats. Tempol supplementation to BSO-treated rats decreased nitrotyrosine, malondialdehyde, and 8-isoprostane levels and increased the tissue glutathione. No significant differences were observed in oxidative or antioxidative markers between vehicle-treated rats and rats that were treated with tempol alone.
Oxidative Stress in BSO-Treated Rats
SKF38393 Failed to Produce Diuresis and Natriuresis in BSO-Treated Rats
Administration of SKF38393 (1 g/kg per min) caused significant increases in fractional excretion of sodium, urinary sodium excretion rate, and urine flow in vehicle-treated rats but not in BSO-treated rats ( Figure 1 ). Treatment with tempol restored SKF38393-induced diuresis and natriuresis in BSOtreated rats. Tempol did not change basal urine output or sodium excretion, and SKF38393 produced diuresis and natriuresis in these rats ( Figure 1 ). No changes in BP or heart rate were observed during SKF38393 infusion (data not shown).
BSO Reduced D1 Receptor [ 3 H]SCH23390 Binding in Renal Proximal Tubular Membranes
As illustrated in Figure 2A , Proximal tubules from BSOtreated rats showed a significant decrease in specific membrane binding of [ 3 H]SCH23390, a D1 receptor antagonist. Similar to vehicle, tempol exerted no effect on ing was markedly decreased in obese rats, whereas immunoblotting experiments revealed similar D1R protein content in cell homogenate as well as membrane and cytosolic fractions in lean and obese rats (7).
BSO Reduced Basal as Well as SKF38393-Induced D1 Receptor G-Protein Coupling in Renal Proximal Tubular Membranes
Incubation of proximal tubular membranes with SKF38393 followed by immunoprecipitation with G␣s antiserum caused a significant increase in [ 35 S]GTP␥S binding in vehicle-treated rats but not in BSO-treated rats. SKF38393-induced D1 receptor G␣s coupling was blocked by D1 antagonist SCH23390, and immunoprecipitation with G␣i failed to show the SKF38393-induced increase in [ 35 S]GTP ␥S in vehicle-treated rats ( Figure  2D ). To assess the basal coupling of D1 receptors to G-proteins, we analyzed direct [ 3 H]SCH23390 binding in immunoprecipitates of G␣s proteins that were obtained from solubilized membranes of renal proximal tubules. The G␣s antiserum-immunoprecipitated [ 3 H]SCH23390 binding sites in BSO-treated rats were significantly reduced compared with vehicle ( Figure 3A) , whereas G␣i antiserum failed to co-immunoprecipitate significant D1 binding sites in vehicle-or BSO-treated rats ( Figure  3A) . Immunoprecipitates of G␣s antisera were also blotted with specific D1 receptor and G␣s antibodies. The D1 receptor protein that co-immunoprecipitated with G␣s was significantly reduced in BSO-treated rats compared with vehicle-treated rats ( Figure 3B ). G␣s antisera immunoprecipitated a similar amount of G␣s protein in both vehicle-and BSO-treated rats ( Figure  3C ).
In vehicle-treated rats, incubation of membranes with SKF38393 caused a significant increase in [ 35 S]GTP␥S membrane binding but failed to produce any effect in BSO-treated rats ( Figure 3D ). Treatment with tempol restored the basal as well as SKF38393-induced D1 receptor G-protein coupling in BSO-treated rats ( Figure 3, A and D) . No difference was observed in D1 receptor coupling between tempol and vehicletreated rats. The basal [
35 S]GTP␥S binding was similar in all four experimental groups ( Table 2) .
BSO Reduced SKF38393-Mediated Adenylyl Cyclase Activation in Renal Proximal Tubular Membranes
Incubation of membranes with SKF38393 increased cAMP accumulation in vehicle-treated rats, but SKF38393 failed to cause a similar increase in cAMP levels in BSO-treated rats (Table 2) . Direct adenylyl cyclase stimulation with forskolin produced similar cAMP accumulation in vehicle-and BSOtreated rats ( Table 2) . As observed in [ 35 S]GTP␥S membrane binding, tempol restored SKF38393-induced adenylyl cyclase stimulation in BSO-treated rats (Table 2) . Tempol did not affect the adenylyl cyclase activity as basal cAMP levels were similar in experimental groups (Table 2) . 
BSO Reduced SKF38393-Induced Na/K-ATPase Inhibition in Renal Proximal Tubules
The incubation of renal proximal tubular cells from vehicletreated animals with SKF38393 resulted in significant inhibition in Na/K-ATPase activity (Figure 4) . Incubation of proximal tubules with SFK38393 from BSO-treated rats failed to cause inhibition in Na/K-ATPase activity (Figure 4) . In rats that were treated with both tempol and BSO, SKF38393-induced inhibition of Na/K-ATPase was comparable to that in vehicle-treated rats (Figure 4) . The basal activities of Na/K-ATPase as well as NHE3 were similar in all experimental groups (Table 2) .
BSO Increased D1 Receptor Phosphorylation and GRK-2 Translocation in Renal Proximal Tubular Membranes
The basal serine phosphorylation of D1A receptors was nearly two-fold higher in proximal tubular membranes from BSO-treated rats compared with vehicle-treated rats ( Figure  5A ). Treatment with tempol normalized receptor hyperphosphorylation in BSO-treated rats. Tempol did not affect the immunoreactivity of D1A protein ( Figure 5A ).
Proximal tubular membranes from BSO-treated rats showed a 60% increase in GRK-2 protein levels compared with those in vehicle-treated rats ( Figure 5B ), whereas the cytosolic fraction from BSO-treated rats showed a significant decrease in GRK-2 protein content ( Figure 5C ), indicating a membranous translocation of GRK-2. The whole-cell lysate from vehicle-and BSOtreated rats showed similar GRK-2 expression ( Figure 5D ). Supplementation of tempol to BSO-treated rats abolished the GRK-2 translocation ( Figure 5E ). Tempol treatment did not change the GRK-2 protein levels ( Figure 5E ).
BSO Increased the PKC Activity and Expression in Renal Proximal Tubules
As shown in Figure 6A , the basal PKC activity was higher in proximal tubular homogenates from BSO-treated rats compared with vehicle-treated rats. Tempol supplementation to BSO-treated rats normalized the PKC activity ( Figure 6A ). There was no difference in PKC activity in rats that were treated with vehicle or tempol alone ( Figure 6A ). a Basal data (n ϭ 8 rats); V versus BSO versus T versus BSO ϩ T were analyzed by one-way ANOVA, whereas within every experimental group, the basal versus SKF38393 versus forskolin were analyzed by repeated measures. Both repeated measures and one-way ANOVA were followed post hoc Newman-Keuls multiple comparison test. P Ͻ 0.05 was considered statistically significant. NHE3, Na/H exchanger 3.
b Significantly different from respective basal.
We also analyzed several PKC isoforms, including ␣, ␤1, ␦, , and . In BSO-treated rats, immunoblotting analysis of these proteins revealed a significant increase in PKC-␦ expression ( Figure 6B ), whereas other isoforms showed NS increases (PKC-␤1 and ) or no change (PKC-␣ and ) in protein levels (data not shown).
BSO Increased the NF-B Nuclear Translocation in Renal Proximal Tubules
Western blot analysis of proximal tubules from BSO-treated rats showed nuclear translocation of NF-B (p65 subunit) as evidenced by increased immunoreactivity of p65 in nucleus ( Figure 7A ) with a comparable decrease in cytosolic fraction ( Figure 7B ). EMSA analysis also revealed that biotin-labeled oligonucleotide probes that comprised an NF-B-specific site formed increased complex with nuclear fraction from BSOtreated rats compared with vehicle-treated rats ( Figure 7, C and  D, lanes 1 through 4) . The protein-DNA complexes were specific because they were competed away by unlabeled probes (Figure 7, C, lanes 5 through 7) . Under similar conditions, no protein--DNA complexes were detected with probes that contained mutations at NF-B sites (data not shown). Tempol supplementation prevented the NF-B translocation in BSOtreated rats (Figure 7) . Tempol did not affect the protein abundance of NF-B (p65), because rats that were treated with tempol or vehicle showed similar NF-B (p65) sequestration ( Figure 7, A and B) .
Discussion
The results of our study show that treatment of SpragueDawley rats with BSO increased oxidative stress and produced an increase in BP, which was accompanied by increased D1 receptor phosphorylation, reduced D1 receptor expression, and coupling to G-proteins in renal proximal tubules. SKF38393, a D1 receptor agonist, failed to stimulate G-proteins and activate adenylyl cyclase in tubular membranes from BSO-treated rats. Also, SKF38393 was unable to inhibit Na/K-ATPase activity and failed to produce diuresis or natriuresis in these rats.
Furthermore, BSO treatment caused NF-B nuclear translocation, increased PKC protein expression and activity, and GRK-2 membranous translocation (Figure 8 ). Supplementation with SOD mimetic compound tempol to BSO-treated rats reduced oxidative stress; normalized BP; and restored renal D1 receptor expression, signaling, and functional response to SKF38393. In addition, tempol abolished NF-B nuclear translocation, decreased PKC activity, and normalized GRK-2 sequestration and D1 receptor serine phosphorylation. These data suggest that elevated oxidative stress impairs renal D1 receptor function via a mechanism that involves nuclear translocation of NF-B, PKC activation, and GRK-2 translocation, which contributes to high BP in these rats.
Oxidative stress can be increased in hypertension by increased production of ROS, including the superoxide anion (O 2 .Ϫ ), the hydroxyl radical, or hydrogen peroxide (H 2 O 2 ), or by a decrease in antioxidant enzymes such as SOD (11) . In this study, treatment of Sprague-Dawley rats with BSO reduced glutathione content, a pivotal endogenous antioxidant, and increased oxidative stress as evidenced by nitrotyrosinylation of proteins and lipid peroxidation. The imbalance in redox status was accompanied by an increase in BP. Treatment of these rats with tempol reduced oxidative stress and normalized BP, indicating the role of oxidative stress in the pathogenesis of hypertension. These findings are in agreement with Vaziri et al. (33) , who showed that BSO can cause protein nitrotyrosinylation and increase BP and that antioxidant supplementation decreases oxidative stress and normalizes BP in these animals. Recent studies also suggested that patients with essential hypertension have decreased antioxidant capability and produce excessive amounts of ROS (11,34 -37) . The activity of SOD and vitamin E levels in erythrocytes are decreased in patients with essential hypertension, and O 2 .Ϫ and H 2 O 2 produced by leukocytes and plasma levels of lipid peroxides are increased in patients with uncontrolled hypertension (11, 37, 38) .
Studies in animal models of hypertension have shown that an increase in oxidative stress is accompanied by reduced renal D1 receptor signaling and that treatment of these animals with antioxidants normalized BP and restored D1 receptor function (7, 13, 14) . Therefore, it is possible that the defect in D1 receptor may serve as a link between hypertension and oxidative stress. This is supported by our finding that treatment of normotensive Sprague-Dawley rats with BSO increased oxidative stress and reduced D1 receptor function and that these rats exhibited an increase in BP. There is substantial evidence for the involvement of D1 receptor dysfunction in the pathogenesis of hypertension in animal models as well as in some cases of human hypertension (1,2,4 -6). In spontaneously hypertensive rats and Dahl salt-sensitive rats, the natriuretic effect of dopamine and D1 receptor agonists is impaired (4 -6,8 -10,31) . Some studies have shown that the inhibitory effect of fenoldopam on renal sodium transporters in proximal tubules is impaired in patients with hypertension (4 -6). We and others have reported that infusion of D1 receptor agonists in obese Zucker rats, a type 2 diabetic model that exhibits oxidative stress and mild hypertension, fails to increase sodium excretion (7,39,40) . Supplementation of these rats with insulin sensitizers or antioxidants Figure 4 . SKF38393, a D1 receptor agonist, induced inhibition of Na/K-ATPase activity in renal proximal tubules from rats that were treated with V, 30 mM BSO, 1 mM T, and BSOϩT. Data are means Ϯ SEM from six to eight rats performed in triplicate. *P Ͻ 0.05, SKF-38393 versus respective control using t test.
decreased oxidative stress, restored D1 receptor function, and normalized BP (7, 40) . Herein, we also observed that antioxidant tempol decreased oxidative stress, restored D1 receptor function, and normalized BP. Taken together, these findings suggest that the D1 receptor defect may serve as a contributing factor to oxidative stress-associated hypertension. Nevertheless, oxidative stress may also contribute to generation and maintenance of hypertension via the inactivation of endothelium-derived relaxing factor such as nitric oxide, the nonenzymatic generation of vasoconstrictive isoprostanes from arachidonic acid, and direct vasopressor action (12, (41) (42) (43) (44) . Antioxidant administration improves nitric oxide metabolism and ameliorates hypertension in rats with lead-induced hypertension or spontaneous hypertension (12, 41) . The inability of renal dopamine to regulate sodium excretion in hypertension may arise from decreased renal dopamine production or failure of dopamine to inhibit sodium transporters (4 -6). In this study, treatment of rats with BSO had no effect on renal dopamine production, because an equal amount of dopamine was excreted by both vehicle-and BSO-treated rats. The abnormal sodium transporters are also an unlikely explanation for failure of D1 receptor stimulation to increase sodium excretion. Both luminal NHE3 and basolateral Na/K-ATPase activities were similar in all experimental groups. Conversely, SKF38393 failed to inhibit Na/K-ATPase activity in proximal tubules from BSO-treated rats compared with vehicle. Treatment of these rats with tempol restored the SKF38393-induced Na/K-ATPase inhibition as well as sodium excretion. Therefore, inability of dopamine to inhibit the Na/K-ATPase may have led to a decrease in sodium excretion and subsequent hypertension in BSO-treated rats. Similar observations were made in obese rats, in which oxidative stress-mediated D1 receptor dysfunction was accompanied by increased BP, and restoration of D1 receptor function with antioxidants reduced oxidative stress and normalized BP (7) .
Radioligand binding with D1 receptor antagonist Data are means Ϯ SEM from six to eight rats performed in triplicate. For A and E, *P Ͻ 0.05, BSO versus other groups using one-way ANOVA followed by post hoc Newman-Keuls multiple test; B and C, *P Ͻ 0.05 BSO versus V using t test.
[ 3 H]SCH23390 revealed a significant decrease in D1 receptor expression in proximal tubules from BSO-treated rats. The decrease in ligand binding was accompanied by uncoupling from cognate G-proteins as activation of D1 receptor failed to stimulate G-proteins. Furthermore, incubation of proximal tubules from BSO-treated rats with SKF38393 failed to increase cAMP accumulation or inhibit Na/K-ATPase, suggesting a defect in D1 receptor-mediated G-protein-coupled signal transduction pathway. Treatment of BSO rats with tempol restored the D1 receptor expression and coupling to G-proteins/effector complex and supports the view that oxidative stress can impair renal D1 receptor signaling and that antioxidants can protect and preserve D1 receptor function. One of the mechanisms by which D1 receptors are uncoupled from G-proteins is through the covalent modifications of the receptor as a consequence of phosphorylation by GRK (17, 19) . Our previous studies in animal models of diabetes and aging associated with oxidative stress suggested that GRK-2 upregulation leads to D1 receptor serine hyperphosphorylation, resulting in receptor desensitization (7, 15) . We found that BSO treatment caused GRK-2 membranous translocation and increased D1 receptor phosphorylation, whereas tempol supplementation decreased GRK-2 membrane abundance and normalized D1 receptor phosphorylation, indicating that GRK-2-mediated D1 receptor phosphorylation could be responsible for D1 receptor G-protein uncoupling. The increased receptor phosphorylation may also explain the basal D1 receptor G-protein uncoupling that was observed in BSO-treated rats. It is of interest that GRK activity and GRK-2 protein abundance are increased in patients with essential hypertension, and GRK-2 has been shown to desensitize D1 receptors in human renal proximal tubules (45) (46) (47) .
The observation that in BSO-treated animals the increased PKC activity was associated with GRK-2 upregulation and tempol whereas reducing PKC activity also normalized GRK-2 translocation indicates a signal transduction cross-talk. In this regard, there are reports to suggest that GRK-2 can be phosphorylated by PKC, which leads to its membrane translocation and increased activity (48, 49) . In a previous study, we found that exposure of renal proximal tubular cells to H 2 O 2 , an oxidant, caused PKC-dependent GRK-2 membrane translocation and subsequent D1 receptor hyperphosphorylation (20) . The D1 receptor hyperphosphorylation and desensitization were specific to GRK-2, because GRK-2 antisense oligonucleotides abolished both receptor phosphorylation and desensitization (20) . Taken together, this study suggests that during oxidative stress, the increased PKC activity leads GRK-2 membrane translocation and subsequent D1 receptor phosphorylation, resulting in D1 receptor desensitization, including its uncoupling from G-proteins.
Evidence to date indicates that oxidative stress increases PKC activity (50); however, the exact mechanism remains to be determined. It has been postulated that NF-B regulates the activities of many intracellular signaling molecules, thereby playing a critical role in determining cellular responses to extracellular stimuli, especially oxidative stress (21-23). One such cross-talk is the activation of PKC activity and expression by NF-B (24) . In this study, the treatment of rats with BSO increased nuclear translocation of NF-B (p65 subunits), which was accompanied by increased PKC-␦ expression. Also, tempol while abolishing NF-B translocation normalized PKC-␦ expression and activity. Therefore, it is possible that oxidative stress activated NF-B, which caused increased PKC expression, thereby increasing its activity. Our findings are supported by reports that in murine embryonic fibroblasts, NF-B positively regulates UV-induced c-Jun N-terminal kinase activation via induction of PKC-␦ activation (24) . In these cells NF-B (Rel A) was shown to bind PKC-␦ promoter site and increase its transcription activity (24) . In addition, UV light failed to activate NF-B-c-Jun N-terminal kinase signaling in PKC-␦ null cells (24) . Conversely, it is also possible that decreased D1R signaling may have contributed to increased PKC-␦ expression in BSO-treated rats.
Conclusion
We have shown that oxidative stress reduces renal D1 receptor function and increases BP in Sprague-Dawley rats. The failure of D1 receptor activation to stimulate G-proteins results in the inability of D1 receptor agonist to inhibit Na/K-ATPase and increase sodium excretion. In addition, our results suggest a novel level of signal cross-talk by showing that oxidative stress-mediated NF-B translocation may increase the PKC-␦ expression and activity. PKC in turn increased GRK-2 translocation, causing D1 receptor phosphorylation and desensitization. Supplementation with antioxidant tempol reduced oxidative stress and normalized intracellular signaling and D1 receptor phosphorylation. Collectively, these phenomena restored D1 receptor function and normalized BP, providing Data are means Ϯ SEM from six to eight rats performed in triplicate. *P Ͻ 0.05, BSO versus other groups using one-way ANOVA followed by post hoc Newman-Keuls multiple test.
strong support for the role of defective D1 receptor function in oxidative stress-mediated hypertension.
